Skip to content

The clinical research of camp of minimally invasive therapy for chronic hypertrophic pharyngitis Xujiang Xie needle thorn

The clinical research of camp of minimally invasive therapy for chronic hypertrophic pharyngitis Xujiang Xie needle thorn

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-16009952
Enrollment
Unknown
Registered
2016-11-21
Start date
2016-11-21
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic hypertrophic pharyngitis

Interventions

experimental group: Xujiang Xie knife stab

Sponsors

The Affiliated Hospital of Jiangxi University of traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1) in accordance with the standard of Western medicine diagnosis of chronic hypertrophic pharyngitis; 2) in accordance with phlegm and blood stasis syndrome of traditional Chinese medicine diagnostic criteria; 3) between 18 and 65 years old; 4) the incidence of the disease in more than 6 months; 5) voluntarily sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1) TCM syndrome elements are complex, can not clearly identify the type of syndrome; 2) at the age of 18 or over the age of 65, or for pregnancy and lactation of pregnant women, allergy 3) chronic pharyngitis accompanied by significantly enlarged tonsil and lower respiratory tract inflammation, chronic throat disease (such as chronic laryngitis, laryngeal cough); 4) for measles, scarlet fever, flu and agranulocytosis, infectious mononucleosis syndrome, leukemia caused by throat symptoms or increased inflammation; 5) by the prosecution confirmed by pharyngeal symptoms of hypopharyngeal and laryngeal, nasopharynx, esophagus and trachea, neck and other occult systemic diseases caused by; 6) serious damage of liver function, abnormal renal function; the combination of heart and cerebral vascular and hematopoietic system of severe primary disease, malignant tumor patients; combined with nerve and mental disorders to cooperation, or reluctant partners; 7) recently used other Chinese and Western medicine treatment of this disease, 1 months participated in other clinical trials of patients

Design outcomes

Primary

MeasureTime frame
Pharyngeal foreign body sensation;Chronic congestion of pharyngeal mucosa;Hypertrophy;Pharyngeal lymphoid follicular hyperplasia;

Secondary

MeasureTime frame
Pharyngeal itching;throat-drying;Sore throat;cough;Expectoration;Pharyngeal cord swelling;Nausea;Abdominal distention;Anorexia;Tongue and pulse;

Countries

China

Contacts

Public ContactDeng Zhengzheng

Department of ENT, the Affiliated Hospital of Jiangxi University of traditional Chinese Medicine

328931997@qq.com+86 13970063622

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026